16 Einträge gefunden

1. Survivorship-Programme: Ziele und Inhalte einer strukturierten Betreuung

   1. Schilling, Georgia
   2. Stein, Alexander
   3. Quidde, Julia
   4. Bokemeyer, Carsten

   2014 - Forschungsinformationssystem des UKE
2. Integrierte onkologische und palliativmedizinische Patientenbetreuung

   1. Oechsle, Karin
   2. Schilling, Georgia

   2012 - Forschungsinformationssystem des UKE
3. [Long-term sequelae of cancer survivors].

   1. Schilling, Georgia
   2. Arnold, Dirk

   2012 - Forschungsinformationssystem des UKE
4. Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.

   1. Kröger, Nicolaus
   2. Shimoni, Avichai
   3. Schilling, Georgia
   4. Schwerdtfeger, Rainer
   5. Bornhäuser, Martin
   6. Nagler, Arnon
   7. Zander, Axel R.

   2010 - Forschungsinformationssystem des UKE
5. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

   1. Pabst, Caroline
   2. Zustin, Jozef
   3. Jacobsen, Frank
   4. Luetkens, Tim
   5. Kröger, Nicolaus
   6. Schilling, Georgia
   7. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
6. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.

   1. Shimoni, Avichai
   2. Hardan, Izhar
   3. Ayuketang Ayuk, Francis
   4. Schilling, Georgia
   5. Atanackovic, Djordje
   6. Zeller, Wolfgang
   7. Yerushalmi, Ronit

   2010 - Forschungsinformationssystem des UKE
7. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

   1. Schilling, Georgia
   2. Bruweleit, Melanie
   3. Harbeck, N
   4. Thomssen, C
   5. Becker, K
   6. Hoffmann, R
   7. Villena, C

   2009 - Forschungsinformationssystem des UKE
8. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
9. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Badbaran, Anita
   3. Lioznov, Michael
   4. Schwartz, Sabine
   5. Zeschke, Silke
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2009 - Forschungsinformationssystem des UKE
10. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.

    1. Murga-Penas, Eva-Maria
    2. Maria, Eva
    3. Callet-Bauchu, Evelyne
    4. Ye, Hongtao
    5. Gazzo, Sophie
    6. Schilling, Georgia
    7. Schilling, Georgia

    2009 - Forschungsinformationssystem des UKE
11. Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.

    1. Schilling, Georgia
    2. Hansen, Timon
    3. Shimoni, A
    4. Zabelina, Tatjana
    5. Pérez-Simón, J-A
    6. Simon-Perez, J-A
    7. Gutierrez, N C

    2008 - Forschungsinformationssystem des UKE
12. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

    1. Atanackovic, Djordje
    2. Arfsten, Julia
    3. Cao, Yanran
    4. Gnjatic, Sacha
    5. Schnieders, Frank
    6. Bartels, Katrin
    7. Schilling, Georgia

    2007 - Forschungsinformationssystem des UKE
13. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

    1. Kröger, Nicolaus-Martin
    2. Schilling, Georgia
    3. Einsele, Hermann
    4. Liebisch, Peter
    5. Shimoni, Avichai
    6. Nagler, Arnon
    7. Perez-Simon, Jose A

    2004 - Forschungsinformationssystem des UKE
14. Dicentric (19;21)(p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome-positive acute lymphoblastic leukemia.

    1. Schilling, Georgia
    2. Dierlamm, Judith
    3. Murga-Penas, Eva-Maria
    4. Hinz, Kristina
    5. Seeger, Doris
    6. Hossfeld, Dieter Kurt

    2004 - Forschungsinformationssystem des UKE
15. Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies.

    1. Dierlamm, Judith
    2. Schilling, Georgia
    3. Michaux, Lucienne
    4. Hinz, Kristina
    5. Murga-Penas, Eva-Maria
    6. Seeger, Doris
    7. Hagemeijer, Anne

    2003 - Forschungsinformationssystem des UKE
16. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.

    1. Murga-Penas, Eva-Maria
    2. Cools, Jan
    3. Algenstaedt, Petra
    4. Hinz, Kristina
    5. Seeger, Doris
    6. Schafhausen, Philippe
    7. Schilling, Georgia

    2003 - Forschungsinformationssystem des UKE